Dr. Bernie Eigl discusses the evolving treatment landscape in muscle invasive bladder cancer at the Vancouver Education Event.
Blog
Dr. Peter Black discusses innovations in non-muscle invasive bladder cancer at the Vancouver Education Event.
An in-depth overview of enfortumab vedotin plus pembrolizumab, the newly approved treatment for advanced bladder cancer.
This presentation provides an in-depth overview of non-muscle invasive bladder cancer, covering risk factors, diagnosis, and treatment options.
A presentation about the surgical management of bladder cancer including TURBT, bladder instillations and radical cystectomy.
An informative webinar exploring the various urinary diversions available to individuals undergoing a radical cystectomy.
A comprehensive overview of bladder cancer, including risk factors, symptoms, diagnosis, staging, grading, and treatment options.
Plain language information on interpreting a bladder cancer pathology report, focusing primarily on cancer grade and stage.
Invaluable perspectives from a panel of BCC Volunteers on diagnosis, treatment decisions, managing side effects, and coping mechanisms.
This presentation provides insights into bladder cancer fundamentals, covering frontline treatment options and latest advancements.